2B70.DE vs. NBTK.DE
2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) and NBTK.DE (Invesco Nasdaq Biotech UCITS ETF) are both Health & Biotech Equities funds tracking the Nasdaq Biotechnology, from iShares and Invesco respectively. Both are passively managed. Over the past 5 years, 2B70.DE returned 5.68%/yr vs 5.63%/yr for NBTK.DE. With a 1.00 correlation, they move nearly in lockstep. 2B70.DE charges 0.35%/yr vs 0.40%/yr for NBTK.DE.
Performance
2B70.DE vs. NBTK.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B70.DE achieves a 4.53% return, which is significantly higher than NBTK.DE's 4.27% return.
2B70.DE
- 1D
- 3.29%
- 1M
- 0.58%
- YTD
- 4.53%
- 6M
- 4.05%
- 1Y
- 39.50%
- 3Y*
- 10.00%
- 5Y*
- 5.68%
- 10Y*
- —
NBTK.DE
- 1D
- 2.92%
- 1M
- 0.38%
- YTD
- 4.27%
- 6M
- 3.76%
- 1Y
- 39.20%
- 3Y*
- 9.94%
- 5Y*
- 5.63%
- 10Y*
- —
2B70.DE vs. NBTK.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 4.53% | 18.62% | 4.60% | 2.56% | -6.29% | 7.59% | 14.52% | 17.20% |
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 4.27% | 18.60% | 4.57% | 2.51% | -6.11% | 7.46% | 14.59% | 17.24% |
Correlation
The correlation between 2B70.DE and NBTK.DE is 1.00 - these two move nearly in lockstep. At this level, holding both provides almost no diversification benefit. If you already own one, adding the other does little to reduce portfolio risk.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 1.00 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.99 |
Correlation (5Y) Calculated over the trailing 5-year period | 1.00 |
Correlation (All Time) Calculated using the full available price history since Oct 22, 2019 | 1.00 |
The correlation between 2B70.DE and NBTK.DE has been stable across timeframes, ranging from 0.99 to 1.00 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B70.DE vs. NBTK.DE — Risk / Return Rank
2B70.DE
NBTK.DE
2B70.DE vs. NBTK.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and Invesco Nasdaq Biotech UCITS ETF (NBTK.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| 2B70.DE | NBTK.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.02 | ||
| Sortino ratioReturn per unit of downside risk | +0.03 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.34 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 6.15 | 6.16 | -0.01 |
| Martin ratioReturn relative to average drawdown | 17.06 | 17.06 | 0.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| 2B70.DE | NBTK.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.04 | 2.03 | +0.02 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | 0.27 | 0.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | 0.42 | -0.06 |
Drawdowns
2B70.DE vs. NBTK.DE - Drawdown Comparison
The maximum 2B70.DE drawdown since its inception was -30.87%, roughly equal to the maximum NBTK.DE drawdown of -30.99%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and NBTK.DE.
Loading charts...
Drawdown Indicators
| 2B70.DE | NBTK.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.87% | -30.99% | +0.12% |
Max Drawdown (1Y)Largest decline over 1 year | -6.33% | -6.24% | -0.09% |
Max Drawdown (3Y)Largest decline over 3 years | -29.34% | -29.35% | +0.01% |
Max Drawdown (5Y)Largest decline over 5 years | -30.87% | -30.99% | +0.12% |
Current DrawdownCurrent decline from peak | -1.26% | -1.44% | +0.18% |
Average DrawdownAverage peak-to-trough decline | -10.01% | -10.62% | +0.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.29% | 2.26% | +0.03% |
Volatility
2B70.DE vs. NBTK.DE - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) have volatilities of 6.65% and 6.41%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B70.DE | NBTK.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.65% | 6.41% | +0.24% |
Volatility (6M)Calculated over the trailing 6-month period | 14.26% | 14.11% | +0.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.09% | 19.00% | +0.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.34% | 20.30% | +0.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.76% | 22.05% | -0.29% |
2B70.DE vs. NBTK.DE - Expense Ratio Comparison
2B70.DE has a 0.35% expense ratio, which is lower than NBTK.DE's 0.40% expense ratio.
Dividends
2B70.DE vs. NBTK.DE - Dividend Comparison
Neither 2B70.DE nor NBTK.DE has paid dividends to shareholders.
Frequently Asked Questions
With a correlation of 1.00, 2B70.DE and NBTK.DE move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
On fees, 2B70.DE is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
2B70.DE is cheaper with a 0.35% expense ratio, compared with 0.40% for NBTK.DE.
Both ETFs track Nasdaq Biotechnology. They also come from different issuers: iShares and Invesco. Their fees differ too: 0.35% for 2B70.DE and 0.40% for NBTK.DE.
Find the right allocation for 2B70.DE and NBTK.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer